We have evaluated a simple dextran sulphate precipitation method for measuring high density lipoprotein cholesterol (HDL) subfractions and have used this method to measure plasma HD~and HDL 3 in a group of 28 patients with primary gout. These patients were found to have significantly lower levels of plasma HDL and HD~than a group of healthy controls, matched for age and sex and of similar body mass index (BMI); no significant difference in mean levels of the HDL 3 subfraction was found however. We have confirmed the high prevalence of hypertriglyceridaemia in subjects with gout compared to controls and the mean serum triglyceride levels were significantly higher (P<O·01) in the gout group than in controls. We have also shown that subjects with high serum triglyceride levels tend to have low plasma HD~concentrations, a finding which is consistent with an inverse relationship between these two parameters. These lipid abnormalities may partly explain the high prevalence of premature atherosclerosis in patients with primary gout.
SUMMARY. We have evaluated a simple dextran sulphate precipitation method for measuring high density lipoprotein cholesterol (HDL) subfractions and have used this method to measure plasma HD~and HDL 3 in a group of 28 patients with primary gout. These patients were found to have significantly lower levels of plasma HDL and HD~than a group of healthy controls, matched for age and sex and of similar body mass index (BMI); no significant difference in mean levels of the HDL 3 subfraction was found however. We have confirmed the high prevalence of hypertriglyceridaemia in subjects with gout compared to controls and the mean serum triglyceride levels were significantly higher (P<O·01) in the gout group than in controls. We have also shown that subjects with high serum triglyceride levels tend to have low plasma HD~concentrations, a finding which is consistent with an inverse relationship between these two parameters. These lipid abnormalities may partly explain the high prevalence of premature atherosclerosis in patients with primary gout.
There is strong epidemiological evidence to suggest an inverse relationship between plasma HDL concentrations and high risk of coronary heart disease (CHD).1-7 The HDL fraction of plasma lipoproteins is heterogeneous. Using preparative ultra-centrifugation it is possible to separate plasma HDL into two main subclasses, HD~and HD~, which have hydrated densities of 1·063-1·125 g/mL and 1·125-1·210 g/mL respectively; recent reports indicate only the former protective against CHD. 8. 9 It has also been found that in physiological and pathological states associated with altered total HDL levels, most variation is due to differences in the HD~subfraction, with little difference in HDL 3 concentrations. 10 Primary gout is a group of metabolic diseases characterised by deposition of monosodium urate monohydrate crystals in joints and soft tissues and which is usually accompanied by raised serum uric acid levels. Some epidemiological studies have Correspondence: Dr G A A Ferns.
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shown a high prevalence of premature atherosclerosis in gout subjects. 11, 12 As hypertriglyceridaemia is common in gout B -17 and it has been shown that serum triglyceride levels are negatively correlated with HDL18, 19 and HD~,20 it was considered likely that concentrations of these lipoproteins would be reduced in patients with primary gout. Naito and Mac-Kenzie 16 have demonstrated significantly lower levels of HDL (using ultra-centrifugation) in patients with primary, assymptomatic gout than in a group of 61 healthy controls. However, their control group had a mean age 8 years younger than the patient group and they took no account of obesity. Using agarose gel electrophoresis and gel scanning, Darlington, Slack and SCOU 21 were unable to show any significant difference in the proportion of a-lipoprotein to total lipoprotein in 180 patients with gout compared with controls matched for age and sex. The gout group was significantly heavier than controls, but weight is lih unreliable index of obesity. Alcohol intake 22 and obesity": 23 are known to effect levels of HDL and its subfractions and Gibson and Grahame'" have suggested both these factors may account for the hypertriglyceridaemia of gout. No previous study has attempted to control for these factors in assessing HDL levels in gout. Therefore we have measured plasma HDL and HDL subclasses in a group of well-documented patients with primary gout to resolve the problem of previous contradictory reports and to see if low levels of these lipoproteins may be a contributing factor to the reported higher incidence of ischaemic heart disease in this group. Conventional ultracentrifugal methods for determining HDL subclasses are time consuming, require expensive equipment and are impractical for large scale screening. We have used a rapid and simple method recently described by Gidez et al.24 The procedure involves initial precipitation of apolipoprotein B containing lipoproteins (very low and low density lipoprotein) according to the method of Warnick and Albers.P This was followed by differential precipitation of HDL 2 from the supernatant using dextran sulphate. Gidez et al. note that the final concentration and molecular weight of dextran sulphate used is critical. 24, 26 To negate any effects of between-batch variation of dextran sulphate we determined the optimum final concentration experimentally, Materials and methods SUBJECTS Twenty-eight patients were recruited from our Rheumatology Clinic. They were diagnosed as having primary gout after excluding secondary causes and then applying the following criteria: (a) four or more typical attacks of acute arthritis with at least one being an attack of podagra in association with hyperuricaemia (a serum uric acid concentration> 0·42 mmol/L); or (b) acute arthritis where uric acid crystals can be demonstrated in the synovial fluid by polarised light microscopy, Patients _were rendered asymptomatic by drug therapy. Age and sex matched controls were obtained from a health screening centre.
Past medical history of ischaemic heart disease and diabetes, a history of drugs and/or consumption of alcohol were sought from all subjects by questionnaire or interview in order to exclude conditions known to be associated with altered HDL levels. Alcohol consumption was scored as follows: no alcohol = l; occasional alcohol = 2; 1-2 drinks/day = 3; 3-5 drinks/day = 4; 6--10 drinks/day = 5, and more than 10 drinks/day = 6. Each subject was measured for height (m) and weight (kg); body mass index (BMI) was calculated according to the formula, BMI = weight (kgj/heighr' (rrr').
SAMPLE COLLECTION
Subjects were fasted overnight for 16 h. 10 mL whole blood was then collected from the subjects into plastic tubes containing 10 mg disodium EDTA. The plasma was separated within 2 h of collection by centrifugation at 1000g for 20 min at room temperature. Plasma samples were deep frozen at -40°C and analysed within 2 weeks of venesection. Clotted samples were also collected for determination of serum triglyceride, cholesterol and uric acid.
SAMPLE ANALYSIS
A fasting blood glucose was determined by an automated glucose oxidase-peroxidase method, to eliminate overt diabetes mellitus. Fasting triglyceride and cholesterol were measured by fully enzymatic methods 27 , 28 using kits provided by Boehringer-Mannheim on a Centrifichem centrifugal analyser (Union Carbide) using Autoset M (Wellcome) as a calibrant and Wellcome quality control serum. Serum uric acid was determined by the method of Sobrinho-Simoes/" using a single channel Technicon AAII auto analyzer . 
MATERIALS

METHODS
Preparation of HDL by heparin-manganese precipitation
This was prepared by the standard heparin manganese chloride method/" using an aliquot of EDTA plasma. 1I20th volume of heparin (7500 iu/ml.) and 1110th volume of manganese chloride (1 mollL) were added sequentially with ',5 be the mean of the 10 values and was used for subsequent analyses of subject samples. a , Validation of the dextran sulphate precipitation method for determining HDL 2 HDL was prepared from the plasma of 37 individuals by the method of Warnick and Albers.r" Aliquots of HDL were taken for cholesterol analysis and for HDL 2 determination by precipitation, using the experimentally derived optimum concentration of dextran sulphate. One millilitre of HDL was placed into an LP3 tube, 100 ul, of dextran sulphate (14,3 mg/mL) was added. Tubes were vortex mixed and incubated at room temperature for 20 min before centrifuging for 30 min at 1000 g and 4°C.
-An aliquot of the HDL r containing supernatant was taken for cholesterol analysis. The cholesterol content of HDL and HDL 3 supernatants were measured using a fully enzymatic cholesterol oxidase-peroxidase method. The same reagent concentrations were used as for total serum cholesterol, but EDTA was added to a concentration of 4 mmollL to prevent interference by manganous ions. 32 Analysis was performed on a Centrifichem centrifugal analyzer (Union Carbide). The
Determination of the optimal dextran sulphate concentration Dose-response curves were constructed for 10 different individuals. The concentration of dextran sulphate at which HD~levels no longer fell steeply ( Fig. 1) was determined for each. The optimum dextran sulphate concentration for selective precipitation of HD~was taken to 528 Ferns et al.
thorough mixing between each addition. Following incubation at 4°C for 30 min, samples were centrifuged for 30 min at 1000 g and 4°C. The supernatants were transferred to a separate tube. Any that appeared turbid were filtered through a 0·22 IlM Millipore filter. 3O An aliquot of the clear supernatant was taken for cholesterol analysis.
Construction of a dose-response curve
Five millilitre aliquots of HDL supernatant, from a single individual, were transferred to a 10 mL plastic tube. 500 ul, of dextran sulphate was added to each and this followed by vortex mixing. 1ncreasing concentrations of dextran sulphate were used to provide a range of final concentrations of dextran sulphate from 0-5 mg/mL. The tubes were left to incubate for 20 min at room temperature before centrifuging for 30 min at 1000 g and at 4°C in a Beckman TJ6 centrifuge. The supernatant was separated and an aliquot taken for cholesterol analysis by the Abell-Kendall reference method.I' The density of 4 mL of clear supernatant was adjusted to 1·125 g/mL by the addition of a solution containing 1·96 mmollL sodium chloride, 3·44 mmollL sodium bromide and 13·4 urnol/L disodium EDTA, and solid sodium bromide. The solution was then centrifuged for 48 h at 120 000 g in an MSE 10 x 10 mL angle head rotor at 200C. The fraction of density (d) <1·125 g/mL was then harvested and made up to its original volume with 0·15 mmollL sodium chloride. The fraction of d> 1·125 g/mL was also similarly collected. The cholesterol content of the fractions was measured by the reference method of Abell-Kendall using the Liebermann Burchard reaction on a Technicon AAII auto analyzer with a Locarte fluorimeter as detector. A dose-response curve of final dextran sulphate concentration against HDL 2 remaining in solution and HDy was thereby constructed (Fig. 1) . At a concentration of o mg/mL of dextran sulphate, the cholesterol content of the fraction of d<I·125 g/mL represents the total HD~content of the specimen. operating conditions were: reagent volume 350 ut., sample volume 15 ilL, incubation time 10 min, automatic blanking, wavelength 520 nm, temperature 37°C; reconstituted lyophilized serum (Wellcome Autoset M) was used as a calibrant. The whole procedure was independently standardised by the Abell-Kendall reference method. HDL z was calculated as the difference between HDL and HDL 3 after correcting for dilution factors. The HDL z of the 37 samples was also determined by preparative ultra-centrifugation using 4 mL of HDL supernatant as previously described. Values of HDL z obtained by the two methods were compared (Fig. 2) . The correlation coefficient was determined and the regression equation calculated by the method of least squares.
Precision
The precision of the assay for HDL z was determined by repeated analyses of pooled plasma samples. An estimate of between-batch precision was obtained by freezing aliquots of HDL supernatant at -40°C and performing the dextran sulphate precipitation at daily intervals.
Determination of HDL subclasses in patient and control subjects
These were determined by the precipitation method using dextran sulphate at a final concentration of 1·3 mg/mL (as described in the section on Validation).
Statistical analysis was performed using Student's paired t-test. 
Results
Dextran sulphate was found to precipitate increasing amounts of HDL 2 from an HDL preparation obtained by heparin manganese precipitation over a concentration range 0·8-5·0 mg/mL. There was a relatively sharp fall in HDL z concentration up to a concentration of 1 mg/mL and further precipitation was found to occur up to 1·3 mg/mL (Fig. 1) . Above this concentration, precipitation was mainly of HDL-3. Ultra-centrifugation of supernatants, prepared after precipitation of HDL z with dextran sulphate, showed that at the lower concentrations (below 1 mg/mL) most of the fall in HDL was due to precipitation of HDL z (d<1'125 g/mL) , with little change in the HDL 3 (d> 1·125 g/mL) fraction (see Fig. 1 ). A good correlation was obtained between HDLz determined by the dextran sulphate precipitation method and by ultra-centrifugation over a wide range of concentrations (Fig. 2) . The optimal final concentration of dextran sulphate was found to be 1·3 mg/mL, and using this concentration the regression equation for HDL z by precipitation vs HDL z by ultracentrifugation was y = 0'79x + 0·026, with a correlation coefficient r = 0·97. The betweenbatch variation for HDL was 7% (at a concentration of 1·1 mmolfL) and 10·7% for HDL z (at a mean concentration of 0·65 mmolfL). It was found necessary to determine the cholesterol content of the HDL 3 supernatant within 6 h of precipitation, since storage at 4°C for longer periods resulted in HDL 3 values of up to 20% lower. Table 1 summarises the data obtained for gout and control groups. Twelve of 28 (43%) patients with gout had hypertriglyceridaemia compared with six of 28 (21%) controls, despite there being no significant difference in alcohol consumption or BMI between the groups. The mean serum triglyceride was also significantly higher in the gout group. Total serum cholesterol, plasma HDL and HDL z were all lower in the gout subjects, but HDL 3 was not significantly different. Nor was there a significant difference in the HDLtotal cholesterol ratio. The HDLz-total cholesterol ratio however was lower (P<0·05) in the gout group. When the gout subjects were allocated to sUbfroups of high and low BMI (30·2±3·51 kg/m and 23·4±2·88 kg/m z respectively) there was found to be no significant difference in mean serum triglyceride, HDLtotal cholesterol nor HDLz-total cholesterol between obese and lean groups (Table 2) . This 
For both groups n = 28; all values are ± standard deviations; "indicates significant difference. 
For both groups n = 14; all values are ± standard deviations; "indicates significant difference. would suggest obesity was not a major determinant affecting these variables in our group. When subjects from control and gout groups were pooled and stratified in terms of serum triglyceride levels, it was found that those with a high triglyceride level (upper quartile) had a significantly lower HDL and HDL 2 than those in the lower quartile (P<O·Ol) ( Table 3) . This data is consistent with previous reports of an inverse relationship between serum triglyceride and HDL and HD~.
Discussion
The dextran sulphate precipitation method of Gidez et al. 24, 26 would appear to be a suitable method for determining plasma HDL 2 concentrations. The procedure is rapid and the cholesterol content of the subfractions can be readily determined enzymatically. The precision of the assay is adequate and largely limited by the precision of the cholesterol assay, especially at low HD~concentrations. A major difficulty with the method is in defining the appropriate concentration of dextran sulphate to use. There appears to be no clear cut-off point when HDL 2 is completely precipitated and all the HDL) remains in the supernatant. Thus the values obtained for HDL 2 depend critically on the concentration of dextran sulphate employed. However, a concentration of dextran sulphate must be chosen so as to avoid the steep portion of the dose-response curve. Failure to do so must inevitably result in poor precision. Gidez and his colleagues have also demonstrated the importance of the molecular weight of the dextran sulphate and its effect on the doseresponse curve. Batch-to-batch variation in the Lipoprotein subfractions from primary gout patients 531 molecular weight of the dextran sulphate there-additional factor contributing to the high fore, may affect the value of the optimal incidence of ischaemic heart disease in this concentration and it would seem to be essential group. to construct a dose-response curve and define the optimal concentration for each batch. The procedure gave good agreement with measurement of HDL 2 by preparative ultra-centrifugation, and values obtained for the normal controls were similar to those obtained by Gidez et at. There are no previous data determined by precipitation published for HDL and HD~in gout subjects. Feldman and Wallace have reported a-lipoprotein levels as a percentage of total lipoproteins to be 16·9±6·6% in 37 patients with gout, compared to 18·9±7·0% in controls]3 and Naito and Mackenzie!" found HDL levels to be 40% lower in 30 subjects with gout compared with 61 controls (0' 75 and 1·23 mmol/L respectively). Our findings are consistent with these data. There is no evidence that drugs commonly used to treat gout result in altered total cholesterol, triglyceride, HDL or HDL 2 levels.P though other drugs are known to do SO. 34 Gibson and Grahame '" suggest that excess alcohol and obesity may account for the hypertriglyceridaemia associated with gout and HDL 2 may be reduced as a consequence. Naito and Mackenzie.!" however, found one-third of patients with primary gout who did not drink excessively also had raised triglyceride levels. Additionally, we found no significant difference in alcohol consumption between our control and gout groups, which would explain the difference in their lipid profiles. There was a small though non-significant difference in BMI between our groups, so this is an unlikely explanation for the difference. The intra-gout group comparison of HDL and HD~in obese and lean subjects also suggests that BMI is not a major determinant.
The differences in HDL subfraction concentrations observed in patients with gout are similar to those seen in patients with insulin dependent diabetesv: 36 and coronary atherosclerosis.f These changes may relate to the raised serum triglyceride levels found in all three groups. Patsch et 01. 20 propose that HDL 2 may be derived from HDL 3 by the acceptance of surface components of phospholipid, cholesterol, and apo-lipoproteins C, which are liberated from VLDL during lipolysis by lipoprotein lipase. If defective lipolysis is the cause of the gouty hypertriglyceridaemia, then HDL 2 levels would also be reduced.
In conclusion, the low HDLrtotal cholesterol ratio found in gout patients may be an
